Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial - Kim CY; Paek SH; Nam DH; Chang JH; Hong YK; Kim JH; Kim OL; Kim SH (Journal of Neuro-Oncology, 2020)
FEMU ID: 41671; EMF-Portal URL: https://www.emf-portal.org/en/article/41671